Cargando…
Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research
Chemotherapy with improved effect in patients with metastatic pancreatic cancer has recently been established, launching a new era for patients with this very aggressive disease. FOLFIRINOX and gemcitabine plus nab-paclitaxel are different regimens, both capable of stabilizing the disease, thus incr...
Autor principal: | Buanes, Trond A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192261/ https://www.ncbi.nlm.nih.gov/pubmed/28082802 http://dx.doi.org/10.3748/wjg.v22.i48.10502 |
Ejemplares similares
-
Opportunities of improvement in the management of pancreatic and periampullary tumors: Prospective evaluation of outcome from a multidisciplinary research program
por: Nordby, Tom, et al.
Publicado: (2013) -
Therapeutic Approaches in Pancreatic Cancer: Recent Updates
por: Kumar, Lokender, et al.
Publicado: (2023) -
Robotic pancreaticoduodenectomy for pancreatic head cancer and periampullary lesions
por: Shyr, Yi‐Ming, et al.
Publicado: (2021) -
Pancreatic ascariasis with periampullary carcinoma
por: Arulprakash, S, et al.
Publicado: (2015) -
Pancreatoduodenectomy for Periampullary Tumors Presenting with Acute Pancreatitis
por: Cao, Xuefeng, et al.
Publicado: (2020)